Clear, practical articles about medicines, active ingredients, treatment areas, and informed next steps.
521 articles found
Erlotinib (sold under the brand name Tarceva) is a targeted antineoplastic medication categorized as a first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It represents a major advancement in precision oncology, offering targeted therapy for specific solid tumor…
Read articleDaclatasvir (sold under the brand name Daklinza) is an advanced direct-acting antiviral (DAA) medication categorized as an HCV NS5A inhibitor. It represents a significant advancement in hepatology, serving as an essential component of modern, interferon-free treatment regimens for chronic Hepatitis…
Read articleSofosbuvir is an advanced direct-acting antiviral (DAA) medication categorized as a nucleotide analog NS5B polymerase inhibitor. It represents a landmark breakthrough in hepatology, serving as the core backbone for modern pan-genotypic treatment regimens for chronic Hepatitis C virus (HCV) infection…
Read articleRibavirin is a broad-spectrum synthetic nucleoside analog antiviral medication. It belongs to a modern class of antiviral agents designed to interfere with viral RNA synthesis and replication. Unlike targeted direct-acting antivirals (DAAs), Ribavirin acts as a systemic antiviral co-agent. It is rar…
Read articleSofosbuvir + Ledipasvir is a highly effective, direct-acting antiviral (DAA) fixed-dose combination therapy used for the treatment of chronic Hepatitis C virus (HCV) infection. This single-tablet regimen combines two potent antiviral agents that directly target and disrupt different stages of the He…
Read articleSofosbuvir + Daclatasvir is a highly effective, direct-acting antiviral (DAA) combination therapy used for the treatment of chronic Hepatitis C virus (HCV) infection. This pan-genotypic regimen combines two distinct viral inhibitors that directly target and disrupt the replication cycle of the Hepat…
Read articleLenvatinib (often administered as Lenvatinib Mesylate) is an advanced targeted oral antineoplastic medication categorized as a multi-targeted receptor tyrosine kinase (RTK) inhibitor. It belongs to a modern class of precision targeted agents designed to selectively block specific cell-surface recept…
Read articleAxitinib is an advanced targeted oral antineoplastic medication categorized as a second-generation multi-targeted receptor tyrosine kinase (RTK) inhibitor. It belongs to a modern class of precision targeted therapies used primarily in the management of advanced kidney cancer (Renal Cell Carcinoma).…
Read articleDasatinib is an advanced targeted oral antineoplastic medication categorized as a second-generation multi-targeted tyrosine kinase inhibitor (TKI). It belongs to a modern class of precision targeted therapies used primarily in the management of specific hematologic malignancies (blood cancers). Engi…
Read articleSunitinib (commonly administered as Sunitinib Malate) is an advanced targeted anticancer therapy categorized as a multi-targeted receptor tyrosine kinase inhibitor (TKI). It belongs to a modern class of precision oncology agents designed to block specific molecular pathways responsible for tumor gro…
Read article
